V
Vensica Medical
A medical device company that is designing and developing and Ultrasound catheter for the treatment of bladder cancer
About Vensica Medical
Vensica is a pioneering company in the field of therapeutic ultrasound and drug delivery, focusing on the urinary bladder. The company leverages the known properties of ultrasound to increase tissue permeability and improve drug uptake. Vensica's core product is a drug delivery platform that uses ultrasound cavitation to safely and effectively deliver Botulinum Toxin A into the bladder wall. This procedure is quick, pain-free, and needle-free, performed in an office setting with minimal expected side effects. Vensica primarily serves patients suffering from overactive bladder (OAB) and bladder cancer, tapping into a market opportunity exceeding $2 billion annually in the U.S. The business model revolves around the development and commercialization of its proprietary drug delivery platform, generating revenue through product sales and potentially licensing agreements.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2024 | $11M | $80M | Merz · Israel Biotech Fund | ↗ |
| LATE VC✓Equity / VC | Feb 2022 | $3M | $80M | Merz | ↗ |
Growth signals
Latest recorded traffic for Vensica Medical is 520 monthly website visits, up 8.3% over the last three months. Vensica Medical's team declined 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Vensica Medical in its local ecosystem
The Vensica Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Cogentix Medical
Series B and later6 investors entered at this stage
Israel Biotech Fund
Trendlines Group
Agriline- LPLew Pell
Laborie
Merz
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vensica Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vensica Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








